(0.05%) 5 471.78 points
(0.08%) 39 142 points
(0.34%) 17 778 points
(-0.07%) $80.77
(-3.66%) $2.66
(-0.77%) $2 312.90
(0.25%) $28.94
(3.59%) $1 021.80
(0.29%) $0.936
(0.70%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders...
Stats | |
---|---|
今日成交量 | 170 627 |
平均成交量 | 0 |
市值 | 40.85M |
EPS | $-0.310 ( Q3 | 2022-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.684 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.104 (10.40%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-02-10 | Aberman Zami | Buy | 80 616 | Common Stock |
2021-05-26 | Clover Wolf Capital - Limited Partnership | Sell | 122 663 | Common Stock |
2021-05-26 | Clover Wolf Capital - Limited Partnership | Sell | 22 015 | Common Stock |
2021-05-27 | Clover Wolf Capital - Limited Partnership | Sell | 71 775 | Common stock |
2021-05-27 | Clover Wolf Capital - Limited Partnership | Sell | 24 110 | Common stock |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 11 245 290 | Sell: 1 084 851 |
音量 相关性
Pluristem Therapeutics 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Pluristem Therapeutics 相关性 - 货币/商品
Pluristem Therapeutics 财务报表
Annual | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.770 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.770 |
FY | 2020 |
营收: | $23 000.00 |
毛利润: | $23 000.00 (100.00 %) |
EPS: | $-1.600 |
FY | 2019 |
营收: | $54 000.00 |
毛利润: | $52 000.00 (96.30 %) |
EPS: | $-2.90 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Pluristem Therapeutics
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA\'s Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。